IP Library Granted Patent US 10,101,571
Granted Patent B2
US 10,101,571 · App. 14/413,106 · Granted Oct 16, 2018

Perfusion assessment multi-modality optical medical device

Inventors: Marc Andre (Spiegel b. Bern, CH); Michael Friedrich (Bern, CH)
Assignee: NOVADAQ TECHNOLOGIES ULC
G02B21/365A61B5/0035A61B5/0261A61B5/7425A61B90/361G02B21/16G02B2207/113
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,101,571
App. No.
14/413,106
Granted
Oct 16, 2018
Kind
B2
Abstract

A perfusion assessment multi-modality optical medical device comprising ⋅ a white light image sensor ( 320 ) and optical system configured to image a body area of interest ( 130, 340 ), a coherent light source ( 330 ) for illuminating said body area of interest with wavelength of 760-810 nm, an optical coherence imaging (OCI) image sensor ( 310 ) detecting the fluctuations of the backscattered light ( 302 ) near the illumination wavelength from at least part of said illuminated body area of interest ( 340 ), a fluorescence image sensor ( 315 ) to detect the fluorescence signal at higher wavelength than the illumination wavelength from at least part of said illuminated body area of interest ( 340 ), a screen ( 115, 210 ) to show the results from the modalities, all previous items being included in a single movable unit ( 200 ) which furthermore comprises a processing unit ( 105, 110 ) to calculate perfusion map from the OCI image sensor ( 310 ) using LDI or LSI algorithms, wherein said white light image sensor ( 320 ), said OCI image sensor ( 310 ) and said fluorescence image sensor ( 315 ), at least partially, use a common optical path ( 610 ).

Claims (31)

1. A perfusion assessment multi-modality optical medical device comprising:

a coherent light source for illuminating a body area of interest;

an optical coherent imaging (OCI) image sensor that detects fluctuations of backscattered light near the illumination wavelength from at least part of said illuminated body area of interest;

a fluorescence image sensor to detect a fluorescence signal at a wavelength different from the illumination wavelength from at least part of said illuminated body area interest;

a screen, the coherent light source, the OCI image sensor, the fluorescence image sensor, and the screen are included in a single movable unit, said OCI image sensor, and said fluorescence image sensor, at least partially, use a common optical path; and

a processing unit coupled to the OCI image sensor and the fluorescence image sensor for comparing the blood flow or perfusion information in the OCI image and in the fluorescence image to differentiate microcirculatory blood perfusion from larger vessels with the blood flow being faster in the larger vessels and wherein the results of the comparison are displayed on the screen.

2. The device according to claim 1 , wherein said OCI image sensor and said fluorescence image sensor are a single image sensor.

3. The device according to claim 1 , further including a white light image sensor and an optical system configured to image the body area of interest and wherein the white light image sensor is configured such that a body area of interest can be shown with at least 1.5×magnification.

4. The device according to claim 1 , further comprising detecting means for the position and orientation of the device head in relation to a patient.

5. The device according to claim 4 , wherein the processing unit renders stored images and/or metadata related to the currently visualized body area.

6. The device according to claim 1 , wherein the processing unit is used to generate an overlay image from the OCI image information and fluorescence image information.

7. The device according to claim 3 , further comprising an auto-focus system for the white light image wherein the focus point is automatically detected by locating the point on the screen which is focused by the user's eye.

8. The device according to claim 1 wherein coherent light source generates a wavelength of 760-810 nm.

9. A perfusion assessment multi-modality optical medical device comprising:

a coherent light source for illuminating a body area of interest;

an optical coherent imaging (OCI) image sensor that detects fluctuations of backscattered light near the illumination wavelength from at least part of said illuminated body area of interest;

a fluorescence image sensor to detect a fluorescence signal at a wavelength different from the illumination wavelength from at least part of said illuminated body area interest, said OCI image sensor, and said fluorescence image sensor, at least partially, use a common optical path;

a screen; and

a processing unit coupled to the OCI image sensor and the fluorescence image sensor for comparing the blood flow information in the OCI image and in the fluorescence image to differentiate the contribution of blood flow in different depths within the body area and wherein the results of the comparison are displayed on the screen.

10. The device according to claim 9 , wherein said OCI image sensor and said fluorescence image sensor are a single image sensor.

11. The device according to claim 9 , further including a white light image sensor and an optical system configured to image the body area of interest.

12. The device according to claim 9 wherein coherent light source generates a wavelength of 760-810 nm.

13. A perfusion assessment multi-modality optical medical device comprising:

a coherent light source for illuminating a body area of interest;

an optical coherent imaging (OCI) image sensor that detects fluctuations of backscattered light near the illumination wavelength from at least part of said illuminated body area of interest;

a fluorescence image sensor to detect a fluorescence signal at wavelength different from the illumination wavelength from at least part of said illuminated body area interest, said OCI image sensor, and said fluorescence image sensor, at least partially, use a common optical path;

a screen; and

a processing unit coupled to the OCI image sensor and the fluorescence image sensor for comparing the blood flow or perfusion information in the OCI image and in the fluorescence image to determine the reliability of the measurements, wherein when the results of the comparison are similar, the measurements are considered more reliable than when the results are different and for generating and displaying on the screen a reliability map.

14. The device according to claim 13 , wherein said OCI image sensor and said fluorescence image sensor are a single image sensor.

15. The device according to claim 13 , further including a white light image sensor and an optical system configured to image the body area of interest.

16. The device according to claim 1 wherein coherent light source generates a wavelength of 760-810 nm.

Assignments (18)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2023
From: STRYKER EUROPEAN OPERATIONS LIMITED
To: STRYKER CORPORATION
Reel/Frame 066140/0647 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053823 FRAME: 0445. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/29/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 056426/0496 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0548. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/30/2017. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 056425/0616 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052860 FRAME: 0900. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 12/31/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 056426/0585 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 044910 FRAME: 0507. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES INC.
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 056425/0530 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICAITON NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053318 FRAME: 0612. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 056425/0731 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0597. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 056426/0352 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 053318/0612 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 052860/0900 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 052873/0548 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 052873/0597 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 053823/0445 →
MERGER AND CHANGE OF NAME Recorded Dec 19, 2017
From: NOVADAQ TECHNOLOGIES INC.; STRYKER CANADA OPERATIONS ULC
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 044910/0507 →
RELEASE OF SECURITY INTEREST Recorded Sep 8, 2017
From: MIDCAP FINANCIAL TRUST
To: NOVADAQ TECHNOLOGIES INC.; NOVADAQ CORP.
Reel/Frame 043788/0799 →
RELEASE OF SECURITY INTEREST Recorded Sep 8, 2017
From: MIDCAP FUNDING IV TRUST (AS SUCCESSOR AGENT TO MIDCAP FINANCIAL TRUST)
To: NOVADAQ TECHNOLOGIES INC.; NOVADAQ CORP.
Reel/Frame 043786/0344 →
SECURITY AGREEMENT (TERM) Recorded Jan 9, 2017
From: NOVADAQ TECHNOLOGIES; NOVADAQ CORP.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 041306/0189 →
SECURITY AGREEMENT (REVOLVING) Recorded Jan 9, 2017
From: NOVADAQ TECHNOLOGIES; NOVADAQ CORP.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 041306/0172 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2015
From: ANDRE, MARC; FRIEDRICH, MICHAEL
To: NOVADAQ TECHNOLOGIES INC.
Reel/Frame 036344/0423 →
Priority Claims (1)
WO PCT/IB2012/053524 · Jul 10, 2012 · international
Continuity (1)
Related Publication 20150198797A1 · Jul 16, 2015
Cited By (3)
US 12,193,831 US 12,231,613 US 12,419,572